Back to Results
First PageMeta Content
Piperazines / Bipolar spectrum / Chemistry / Mood disorders / Bipolar disorder / Quetiapine / Bipolar I disorder / Antipsychotic / Olanzapine / Emotion / Psychiatry / Atypical antipsychotics


Open Document

File Size: 220,46 KB

Share Result on Facebook

City

Washington / DC / Lanusei / Keck / Kelley / /

Company

BP / Creative Commons / BioMed Central Ltd. / /

Country

Italy / /

/

Event

Product Issues / /

Facility

University of Cagliari / /

IndustryTerm

treatment of patients with bipolar disorder / treatment of patients with bipolar I disorder / treatment for bipolar I disorder / /

MedicalCondition

severe and chronic illness / disease / I disorder / bipolar depression / rapid cycling bipolar disorders / mania / bipolar disorders / drowsiness / rapid cycling disease / drug abuse / illness / depression / tardive dyskinesia / Bipolar Disorder / hypotension / /

Organization

University of Cagliari / Italy and 2AUSL / Department of Public Health / /

Person

Maria Carolina Hardoy / Mauro Giovanni Carta / Maria Carolina / Alessandra Garofalo / Francesco Tuligi / Paul Nurse / /

/

Position

Nurse / scientist / Corresponding author / /

Product

Olanzapine / Quetiapine / Ongoing medications* Medication / Haloperidol / Gabapentin / Carbamazepine / Risperidone / Oxcarbazepine / divalproex / response / /

Technology

CGI / evaluated using the CGI-BP scale / /

URL

http /

SocialTag